MDRX : Summary for Allscripts Healthcare Solutions - Yahoo Finance

U.S. Markets open in 2 hrs 14 mins

Allscripts Healthcare Solutions, Inc. (MDRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
11.42-0.03 (-0.26%)
At close: 4:00PM EST
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close11.45
Bid6.12 x 100
Ask0.00 x
Day's Range11.23 - 11.70
52 Week Range9.80 - 15.17
Avg. Volume2,519,696
Market Cap2.11B
PE Ratio (TTM)-101.06
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube4 days ago

    ETFs with exposure to Allscripts Healthcare Solutions, Inc. : January 19, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Allscripts Healthcare Solutions, Inc. Here are 5 ETFs with the largest exposure to MDRX-US. Comparing the performance and risk of Allscripts Healthcare Solutions, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • GlobeNewswire4 days ago

    Allscripts expands leadership team; heightening focus on client support, international growth

    CHICAGO, Jan. 19, 2017-- Allscripts Healthcare Solutions, a global leader in healthcare information technology, announced two additions to its executive team. Lisa Khorey joined Allscripts in the newly ...

  • Barrons.com12 days ago

    [$$] Allscripts: Curb Your Enthusiasm

    After Monday’s market close, Allscripts provided a preliminary financial outlook for the fourth quarter and 2017. Allscripts expects record quarterly bookings for the quarter of greater than $400 million, versus our estimate of $380 million. It reaffirmed its prior financial guidance for fourth-quarter for non-GAAP revenue of $420 million-$435 million in line with our estimate of $424.2 million and consensus of $422.2 million, adjusted net earnings before interest, taxes, depreciation and amortization (Ebitda) of $70 million-$80 million, and non-GAAP EPS of 14 cents-16 cents in line with our estimate of 16 cents and consensus of 15 cents.